大幅杀溢价！可转债这些风险值得警惕

Core Viewpoint - The significant decline in Feikai Convertible Bond and Huaxiang Convertible Bond is primarily due to the announcement of early redemption by both companies, leading to a negative conversion premium in the current market environment [1][4][5]. Group 1: Market Reaction - Feikai Convertible Bond dropped by 10.18%, closing at 113.534 CNY per bond, while Huaxiang Convertible Bond fell by 6.97%, closing at 122.764 CNY per bond [2]. - Both convertible bonds experienced a negative conversion premium, indicating a rapid decrease in their time value due to the early redemption announcements [1][4]. Group 2: Company Announcements - Feikai announced that from March 27 to April 25, its stock price had met the condition for early redemption, with 15 trading days closing above 120% of the conversion price of 15.30 CNY per share [4][5]. - Huaxiang similarly triggered its early redemption clause, with its stock price closing above 130% of the conversion price of 11.65 CNY per share for 15 out of 25 trading days [5]. Group 3: Implications of Early Redemption - The early redemption of convertible bonds reduces their time value, compressing the conversion premium to near zero, which negatively impacts bond prices [6]. - Investors are advised to closely analyze the terms of the bonds and adjust their positions to mitigate potential losses from the early redemption [1][6]. Group 4: Broader Market Concerns - Investors should also be aware of the potential delisting risks associated with convertible bonds, particularly as some underperforming companies may trigger delisting scenarios [7][8]. - The case of Puli Pharmaceutical illustrates the risks, as its stock and convertible bonds faced significant declines due to impending delisting, with the convertible bond dropping by 18.13% [8][10].